Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries. CA Cancer J Clin 71:209–249. https://doi.org/10.3322/caac.21660

Article  PubMed  Google Scholar 

Early Breast Cancer Trialists’ Collaborative (2018) Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials. Lancet Oncol 19:27–39. https://doi.org/10.1016/S1470-2045(17)30777-5

Article  Google Scholar 

Cortazar P, Zhang L, Untch M, Mehta K, Costantino JP, Wolmark N, Bonnefoi H, Cameron D, Gianni L, Valagussa P, Swain SM, Prowell T, Loibl S, Wickerham DL, Bogaerts J, Baselga J, Perou C, Blumenthal G, Blohmer J, Mamounas EP, Bergh J, Semiglazov V, Justice R, Eidtmann H, Paik S, Piccart M, Sridhara R, Fasching PA, Slaets L, Tang S, Gerber B, Geyer CE, Pazdur R, Ditsch N, Rastogi P, Eiermann W, von Minckwitz G (2014) Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. Lancet 384:164–172. https://doi.org/10.1016/S0140-6736(13)62422-8

Article  PubMed  Google Scholar 

Spring LM, Fell G, Arfe A, Sharma C, Greenup R, Reynolds KL, Smith BL, Alexander B, Moy B, Isakoff SJ, Parmigiani G, Trippa L, Bardia A (2020) Pathologic complete response after neoadjuvant chemotherapy and impact on breast cancer recurrence and survival: a comprehensive meta-analysis. Clin Cancer Res 26:2838–2848. https://doi.org/10.1158/1078-0432.CCR-19-3492

Article  PubMed  PubMed Central  Google Scholar 

Boughey JC, Ballman KV, McCall LM, Mittendorf EA, Symmans WF, Julian TB, Byrd D, Hunt KK (2017) Tumor biology and response to chemotherapy impact breast cancer-specific survival in node-positive breast cancer patients treated with neoadjuvant chemotherapy: long-term follow-up from ACOSOG Z1071 (Alliance). Ann Surg. https://doi.org/10.1097/SLA.0000000000002373

Article  PubMed  Google Scholar 

Symmans WF, Wei C, Gould R, Yu X, Zhang Y, Liu M, Walls A, Bousamra A, Ramineni M, Sinn B, Hunt K, Buchholz TA, Valero V, Buzdar AU, Yang W, Brewster AM, Moulder S, Pusztai L, Hatzis C, Hortobagyi GN (2017) Long-term prognostic risk after neoadjuvant chemotherapy associated with residual cancer burden and breast cancer subtype. J Clin Oncol 35:1049–1060. https://doi.org/10.1200/JCO.2015.63.1010

Article  CAS  PubMed  PubMed Central  Google Scholar 

Teshome M, Kuerer HM (2017) Breast conserving surgery and locoregional control after neoadjuvant chemotherapy. Eur J Surg Oncol 43:865–874. https://doi.org/10.1016/j.ejso.2017.02.002

Article  CAS  PubMed  Google Scholar 

Haque W, Verma V, Hatch S, Suzanne Klimberg V, Brian Butler E, Teh BS (2018) Response rates and pathologic complete response by breast cancer molecular subtype following neoadjuvant chemotherapy. Breast Cancer Res Treat 170:559–567. https://doi.org/10.1007/s10549-018-4801-3

Article  CAS  PubMed  Google Scholar 

Volders JH, Haloua MH, Krekel NM, Negenborn VL, Barbe E, Sietses C, Jozwiak K, Meijer S, van den Tol MP (2016) Neoadjuvant chemotherapy in breast-conserving surgery - Consequences on margin status and excision volumes: A nationwide pathology study. Eur J Surg Oncol 42:986–993. https://doi.org/10.1016/j.ejso.2016.02.252

Article  CAS  PubMed  Google Scholar 

Shin HJ, Kim HH, Ahn JH, Kim SB, Jung KH, Gong G, Son BH, Ahn SH (2011) Comparison of mammography, sonography, MRI and clinical examination in patients with locally advanced or inflammatory breast cancer who underwent neoadjuvant chemotherapy. Br J Radiol 84:612–620. https://doi.org/10.1259/bjr/74430952

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yeh E, Slanetz P, Kopans DB, Rafferty E, Georgian-Smith D, Moy L, Halpern E, Moore R, Kuter I, Taghian A (2005) Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer. AJR Am J Roentgenol 184:868–877. https://doi.org/10.2214/ajr.184.3.01840868

Article  PubMed  Google Scholar 

Scheel JR, Kim E, Partridge SC, Lehman CD, Rosen MA, Bernreuter WK, Pisano ED, Marques HS, Morris EA, Weatherall PT, Polin SM, Newstead GM, Esserman LJ, Schnall MD, Hylton NM (2018) MRI, clinical examination, and mammography for preoperative assessment of residual disease and pathologic complete response after neoadjuvant chemotherapy for breast cancer: ACRIN 6657 trial. AJR Am J Roentgenol 210:1376–1385. https://doi.org/10.2214/ajr.17.18323

Article  PubMed  PubMed Central  Google Scholar 

Marinovich ML, Macaskill P, Irwig L, Sardanelli F, Mamounas E, von Minckwitz G, Guarneri V, Partridge SC, Wright FC, Choi JH, Bhattacharyya M, Martincich L, Yeh E, Londero V, Houssami N (2015) Agreement between MRI and pathologic breast tumor size after neoadjuvant chemotherapy, and comparison with alternative tests: individual patient data meta-analysis. BMC Cancer 15:662. https://doi.org/10.1186/s12885-015-1664-4

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ballesio L, Gigli S, Di Pastena F, Giraldi G, Manganaro L, Anastasi E, Catalano C (2017) Magnetic resonance imaging tumor regression shrinkage patterns after neoadjuvant chemotherapy in patients with locally advanced breast cancer: Correlation with tumor biological subtypes and pathological response after therapy. Tumour Biol 39:1010428317694540. https://doi.org/10.1177/1010428317694540

Article  CAS  PubMed  Google Scholar 

Um E, Kang JW, Lee S, Kim HJ, Yoon TI, Sohn G, Chung IY, Kim J, Lee JW, Son BH, Ahn SH, Ko BS (2018) Comparing accuracy of mammography and magnetic resonance imaging for residual calcified lesions in breast cancer patients undergoing neoadjuvant systemic therapy. Clin Breast Cancer 18:e1087–e1091. https://doi.org/10.1016/j.clbc.2018.03.011

Article  PubMed  Google Scholar 

Zhou J, Li G, Sheng F, Qiao P, Zhang H, Xing X (2016) Magnetic resonance imaging evaluation of residual tumors in breast cancer after neoadjuvant chemotherapy: surgical implications. Acta Radiol 57:529–537. https://doi.org/10.1177/0284185115597263

Article  PubMed  Google Scholar 

Diguisto C, Ouldamer L, Arbion F, Vildé A, Body G (2015) MRI evaluation of residual breast cancer after neoadjuvant chemotherapy: influence of patient, tumor and chemotherapy characteristics on the correlation with pathological response. Anticancer Res 35:581–585

PubMed  Google Scholar 

Williams M, Eatrides J, Kim J, Talwar H, Esposito N, Szabunio M, Ismail-Khan R, Kiluk J, Lee M, Laronga C, Khakpour N (2013) Comparison of breast magnetic resonance imaging clinical tumor size with pathologic tumor size in patients status post-neoadjuvant chemotherapy. Am J Surg 206:567–573. https://doi.org/10.1016/j.amjsurg.2013.02.006

Article  PubMed  Google Scholar 

Loo CE, Straver ME, Rodenhuis S, Muller SH, Wesseling J, Vrancken Peeters MJ, Gilhuijs KG (2011) Magnetic resonance imaging response monitoring of breast cancer during neoadjuvant chemotherapy: relevance of breast cancer subtype. J Clin Oncol 29:660–666. https://doi.org/10.1200/JCO.2010.31.1258

Article  PubMed  Google Scholar 

Wright FC, Zubovits J, Gardner S, Fitzgerald B, Clemons M, Quan ML, Causer P (2010) Optimal assessment of residual disease after neo-adjuvant therapy for locally advanced and inflammatory breast cancer–clinical examination, mammography, or magnetic resonance imaging? J Surg Oncol 101:604–610. https://doi.org/10.1002/jso.21559

Article  CAS  PubMed  Google Scholar 

Price ER, Wong J, Mukhtar R, Hylton N, Esserman LJ (2015) How to use magnetic resonance imaging following neoadjuvant chemotherapy in locally advanced breast cancer. World J Clin Cases 3:607–613. https://doi.org/10.12998/wjcc.v3.i7.607

Article  PubMed  PubMed Central  Google Scholar 

Mukhtar RA, Yau C, Rosen M, Tandon VJ (2013) Clinically meaningful tumor reduction rates vary by prechemotherapy MRI phenotype and tumor subtype in the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657). Ann Surg Oncol 20:3823–3830. https://doi.org/10.1245/s10434-013-3038-y

Article  PubMed  PubMed Central  Google Scholar 

De Los SJ, Bernreuter W, Keene K, Krontiras H, Carpenter J, Bland K, Cantor A, Forero A (2011) Accuracy of breast magnetic resonance imaging in predicting pathologic response in patients treated with neoadjuvant chemotherapy. Clin Breast Cancer 11:312–319. https://doi.org/10.1016/j.clbc.2011.06.007

Article  Google Scholar 

Gomez-Raposo C, Andreu M, Suarez-Garcia I, Esteban MI, Carballo M, Sereno-Moyano MF, Vazquez Osorio JL, Heras J, Zambrana Tevar F, Pelayo E, Lopez-Gomez M, Garcia de Santiago C, Merino Salvador M, Casado E (2012) Relevance of breast cancer subtypes for magnetic resonance imaging response monitoring during neoadjuvant chemotherapy. Clin Transl Oncol 14:486–488. https://doi.org/10.1007/s12094-012-0828-9

Article  CAS  PubMed  Google Scholar 

Kuzucan A, Chen JH, Bahri S, Mehta RS, Carpenter PM, Fwu PT, Yu HJ, Hsiang DJ, Lane KT, Butler JA, Feig SA, Su MY (2012) Diagnostic performance of magnetic resonance imaging for assessing tumor response in patients with HER2-negative breast cancer receiving neoadjuvant chemotherapy is associated with molecular biomarker profile. Clin Breast Cancer 12:110–118. https://doi.org/10.1016/j.clbc.2012.01.009

Article  PubMed  PubMed Central  Google Scholar 

Ranganathan P, Pramesh CS, Aggarwal R (2017) Common pitfalls in statistical analysis: Measures of agreement. Perspect Clin Res 8:187–191. https://doi.org/10.4103/picr.PICR_123_17

Article  PubMed  PubMed Central  Google Scholar 

Kim J, Han B-K, Ko EY, Ko ES, Choi JS, Park KW (2022) Prediction of pathologic complete response on MRI in patients with breast cancer receiving neoadjuvant chemotherapy according to molecular subtypes. Eur Radiol 32:4056–4066. https://doi.org/10.1007/s00330-021-08461-0

Article  CAS  PubMed  Google Scholar 

Weber JJ, Jochelson MS, Eaton A, Zabor EC, Barrio AV, Gemignani ML, Pilewskie M, Van Zee KJ, Morrow M, El-Tamer M (2017) MRI and prediction of pathologic complete response in the breast and axilla after neoadjuvant chemotherapy for breast cancer. J Am Coll Surg 225:740–746. https://doi.org/10.1016/j.jamcollsurg.2017.08.027

Article  PubMed  PubMed Central  Google Scholar 

Marinovich ML, Macaskill P, Irwig L, Sardanelli F, von Minckwitz G, Mamounas E, Brennan M, Ciatto S, Houssami N (2013) Meta-analysis of agreement between MRI and pathologic breast tumour size after neoadjuvant chemotherapy. Br J Cancer 109:1528–1536. https://doi.org/10.1038/bjc.2013.473

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vriens BE, de Vries B, Lobbes MB, van Gastel SM, van den Berkmortel FW, Smilde TJ, van Warmerdam LJ, de Boer M, van Spronsen DJ, Smidt ML, Peer PG, Aarts MJ, Tjan-Heijnen VC (2016) Ultrasound is at least as good as magnetic resonance imaging in predicting tumour size post-neoadjuvant chemotherapy in breast cancer. Eur J Cancer 52:67–76. https://doi.org/10.1016/j.ejca.2015.10.010

Article  PubMed